Stay updated on VX15/Avelumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.

Latest updates to the VX15/Avelumab Combo in NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe page shows a new revision number (v3.6.6), indicating a minor update to the study record rather than substantive changes to the content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small backend or UI update rather than changes to the study information.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous revision label. This indicates a software or UI update, with no changes to the study details or visible content.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page shows a new revision tag (v3.6.3) replacing the previous v3.6.0, indicating a minor system update to the study page.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page now indicates that no participants are being recruited. New help and navigation entries were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated along with a revision note from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check91 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor update to the page's documentation/versioning rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to VX15/Avelumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.